Masterclass @BrighamWomens Grand Rounds by @TorBiering
Remarkable breadth of high quality randomized evidence being generated by efficiently leveraging the Danish nationwide registries
The future of clinical trials is here!
An early #afib ablation strategy should be considered in patients with symptomatic AF.
Our newly published paper in @JAHA_AHA demonstrates that ablation timing appears to be crucial
DOI: 10.1161/JAHA.123.032722
@CopCard@CopGAG @MRuwald @SamKSorensen@DrJasonAndrade@drjohnm
❕In pts surviving #IE - recurrence of #bacteremia or #IE is feared😧
Using nationwide 🇩🇰 data, the authors @EmilFosb et al. found that recurrent #bacteremia w/ the same bacterial species within 12 months, occurred in almost 5% and 2.6% for recurrent #IE🦠
@ClinMedJournals
Klimaændringer - en Hjertesag ❤️
Delte mine tanker om #Klimaændringer og sundhedsrisiko på News & Co. 👩⚕️🌍
Vi skal tage alvorligt, hvordan stigende temperaturer påvirker vores ældre. Det handler om at forebygge sundhedsrisici og styrke vores samfund mod fremtidige hedebølger.
This newly published study in @JAMACardio by dr. @HaversEva et al. suggests that #preeclampsia is associated with a significantly increased risk of #VTE🩸during #pregnancy,🤰during the puerperium, and after the puerperium - even after thorough adjustment #cardioTwitter
👩🔬 @carogarred findings presented at the @HerlevGentofte research symposium are thought-provoking. She's shedding light on the lack of improvements in risk of death in octogenarians 👵 with heart failure 💔 compared to younger patients. 🧐 Important insights 🏥
Exciting moment at the @HerlevGentofte research symposium! Regitze Hein is revealing the benefits of a shorter time ⏱️ to ablation for patients with atrial fibrillation. ⚡️
🌟 Noor Abassi presenting at the @HerlevGentofte research symposium. She's delving into the risk of death in a #HeartFailure population, categorizing them by their #frailty scores. Valuable research to enhance care for vulnerable patients.
Exciting presentation at the @HerlevGentofte research symposium. Marte Austreim is shedding light on the risk of death and adverse effects for heart failure (#HF) patients with and without atrial fibrillation (#AF). 🏥 Important insights for better patient care💡👩🔬
Great to chair the presentation with @jas_soar about news within defibrillation ⚡️❤️. Impressive talks by Giuseppe Ristagno (AMSA), Ian Drennan (Dual seq. defib) and Andreas Claesson (drone AED delivery)! The future of defibrillation!
@ERC_resus@CopCard@akutberedskabet
Less might be better in the sickest patients 🚨
In this just published sub-study of the #BOX trial, early lactate 🩸modified the effect of blood pressure target on 1⃣ year mortality in resuscitated #OHCA patients 🫀
A new sdy by Dr. Rasmus P. Beske et al. in @ResusJournal 📜
Emerging insights into infective #endocarditis 🦠 demonstrate significant #sex disparities 💔 While females face ⬆️ in-hospital mortality, long-term outcomes align with their male counterparts. Emphasising the critical need to address sex-related distinctions in healthcare 👩🏼🧔🏽♂️
Do we overloook public #OHCAs in residential neighborhoods? In this @JACCJournals study, we found 2/3 of public OHCA in residential neighborhoods with ⬇️ CPR, ⬇️ defibrillation, and ⬇️ survival.
https://t.co/64s9Ny7Xvx
@cmaltahansen @FolkeFredrik@krychtiukmd @trygfonden
What is the relationship between red cell distribution width (RDW)🩸and outcomes, and the effect of sacubitril/valsartan, compared with valsartan, on RDW and outcomes? 🫀 💊
Go read the newest findings from the #ParagonHF trial by Dr. @JawadHButt et al. 📜 #RCT#RigsHeart